iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $84.63 million. The enterprise value is -$69.14 million.
Important Dates
The next estimated earnings date is Thursday, December 26, 2024, before market open.
| Earnings Date | Dec 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
iHuman has 52.37 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 52.37M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 70.27% |
| Owned by Institutions (%) | 0.34% |
| Float | 15.57M |
Valuation Ratios
The trailing PE ratio is 4.96.
| PE Ratio | 4.96 |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| Forward PS | n/a |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.89 |
| Quick Ratio | 2.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.79% and return on invested capital (ROIC) is 6.87%.
| Return on Equity (ROE) | 14.79% |
| Return on Assets (ROA) | 4.56% |
| Return on Capital (ROIC) | 6.87% |
| Revenue Per Employee | $169,078 |
| Profits Per Employee | $23,225 |
| Employee Count | 783 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 16.21 |
Taxes
In the past 12 months, iHuman has paid $1.83 million in taxes.
| Income Tax | 1.83M |
| Effective Tax Rate | 9.16% |
Stock Price Statistics
The stock price has decreased by -37.40% in the last 52 weeks. The beta is 0.47, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -37.40% |
| 50-Day Moving Average | 1.81 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 36.95 |
| Average Volume (20 Days) | 19,415 |
Short Selling Information
| Short Interest | 4,438 |
| Short Previous Month | 3,254 |
| Short % of Shares Out | 0.02% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, iHuman had revenue of $132.39 million and earned $18.19 million in profits. Earnings per share was $0.33.
| Revenue | 132.39M |
| Gross Profit | 94.22M |
| Operating Income | 13.57M |
| Pretax Income | 23.18M |
| Net Income | 18.19M |
| EBITDA | 15.23M |
| EBIT | 13.57M |
| Earnings Per Share (EPS) | $0.33 |
Full Income StatementBalance Sheet
The company has $155.42 million in cash and $395,079 in debt, giving a net cash position of $155.02 million or $2.96 per share.
| Cash & Cash Equivalents | 155.42M |
| Total Debt | 395,079 |
| Net Cash | 155.02M |
| Net Cash Per Share | $2.96 |
| Equity (Book Value) | 125.10M |
| Book Value Per Share | 2.39 |
| Working Capital | 116.69M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 71.17%, with operating and profit margins of 10.25% and 13.74%.
| Gross Margin | 71.17% |
| Operating Margin | 10.25% |
| Pretax Margin | 15.12% |
| Profit Margin | 13.74% |
| EBITDA Margin | 11.51% |
| EBIT Margin | 10.25% |
| FCF Margin | n/a |